
Mary M. Lyons
Examiner (ID: 4587, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1653 |
| Total Applications | 674 |
| Issued Applications | 377 |
| Pending Applications | 90 |
| Abandoned Applications | 228 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14439055
[patent_doc_number] => 20190177400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => BIOLOGICAL UPGRADING OF HYDROCARBON STREAMS WITH NICKEL-BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/186746
[patent_app_country] => US
[patent_app_date] => 2018-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16186746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/186746 | BIOLOGICAL UPGRADING OF HYDROCARBON STREAMS WITH NICKEL-BINDING PROTEINS | Nov 11, 2018 | Abandoned |
Array
(
[id] => 16398779
[patent_doc_number] => 20200339637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => PROMOTER POLYNUCLEOTIDE, SIGNAL POLYPEPTIDE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/959058
[patent_app_country] => US
[patent_app_date] => 2018-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959058 | Promoter polynucleotide, signal polypeptide and use thereof | Nov 7, 2018 | Issued |
Array
(
[id] => 18342453
[patent_doc_number] => 11639930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against
[patent_app_type] => utility
[patent_app_number] => 16/761034
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13645
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761034 | Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against | Oct 31, 2018 | Issued |
Array
(
[id] => 16688751
[patent_doc_number] => 20210071227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHOD AND DEVICE FOR THE QUALITATIVE AND QUANTITATIVE DETECTION OF BIOFILM-BUILDING BACTERIA CONTAINED IN AN AQUATIC SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/771937
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771937 | METHOD AND DEVICE FOR THE QUALITATIVE AND QUANTITATIVE DETECTION OF BIOFILM-BUILDING BACTERIA CONTAINED IN AN AQUATIC SYSTEM | Oct 30, 2018 | Abandoned |
Array
(
[id] => 18604915
[patent_doc_number] => 11746370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Methods and compositions for assessing and treating intraocular diseases and disorders
[patent_app_type] => utility
[patent_app_number] => 16/758365
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 28758
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758365 | Methods and compositions for assessing and treating intraocular diseases and disorders | Oct 25, 2018 | Issued |
Array
(
[id] => 14213951
[patent_doc_number] => 20190119360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => TEMPERATURE SHIFT FOR HIGH YIELD EXPRESSION OF POLYPEPTIDES IN YEAST AND OTHER TRANSFORMED CELLS
[patent_app_type] => utility
[patent_app_number] => 16/169130
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16169130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/169130 | None | Oct 23, 2018 | Issued |
Array
(
[id] => 14016579
[patent_doc_number] => 20190070283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/166708
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166708 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | Oct 21, 2018 | Abandoned |
Array
(
[id] => 16253849
[patent_doc_number] => 20200263223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => MICROBIOME HEALTH INDEX
[patent_app_type] => utility
[patent_app_number] => 16/651469
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651469 | MICROBIOME HEALTH INDEX | Oct 11, 2018 | Abandoned |
Array
(
[id] => 15052311
[patent_doc_number] => 10456431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Treatment of clostridium difficile infection
[patent_app_type] => utility
[patent_app_number] => 16/157640
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 74
[patent_no_of_words] => 51420
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157640 | Treatment of clostridium difficile infection | Oct 10, 2018 | Issued |
Array
(
[id] => 16030771
[patent_doc_number] => 10677796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Method for the quantification of parasite eggs in feces
[patent_app_type] => utility
[patent_app_number] => 16/154371
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 19678
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/154371 | Method for the quantification of parasite eggs in feces | Oct 7, 2018 | Issued |
Array
(
[id] => 14435707
[patent_doc_number] => 20190175725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => Prophylactic and Immunomodulatory Compositions and Uses
[patent_app_type] => utility
[patent_app_number] => 16/152910
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16152910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/152910 | Prophylactic and Immunomodulatory Compositions and Uses | Oct 4, 2018 | Abandoned |
Array
(
[id] => 17742787
[patent_doc_number] => 11390844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Use of compositions containing
[patent_app_type] => utility
[patent_app_number] => 16/753636
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12926
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753636
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753636 | Use of compositions containing | Oct 4, 2018 | Issued |
Array
(
[id] => 14132371
[patent_doc_number] => 20190100575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND A STAPHYLOCOCCUS TARGET ANTIGEN AND A COMPLEMENT COMPONENT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/143901
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143901 | Bispecific antigen-binding molecules that bind a | Sep 26, 2018 | Issued |
Array
(
[id] => 17554955
[patent_doc_number] => 11311612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Compositions and methods for generating an immune response to treat or prevent malaria
[patent_app_type] => utility
[patent_app_number] => 16/648693
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13947
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648693 | Compositions and methods for generating an immune response to treat or prevent malaria | Sep 17, 2018 | Issued |
Array
(
[id] => 13773103
[patent_doc_number] => 20190000090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => BIOFILMS, COMPONENTS AND METHODS OF USE TO REDUCE BIOFOULING AND CONTAMINATION
[patent_app_type] => utility
[patent_app_number] => 16/123570
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123570 | BIOFILMS, COMPONENTS AND METHODS OF USE TO REDUCE BIOFOULING AND CONTAMINATION | Sep 5, 2018 | Abandoned |
Array
(
[id] => 19622911
[patent_doc_number] => 12161703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders
[patent_app_type] => utility
[patent_app_number] => 16/643320
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15105
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643320 | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders | Aug 27, 2018 | Issued |
Array
(
[id] => 14040733
[patent_doc_number] => 20190076473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
[patent_app_type] => utility
[patent_app_number] => 16/115128
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/115128 | AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS | Aug 27, 2018 | Abandoned |
Array
(
[id] => 16236852
[patent_doc_number] => 20200254086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => EFFICACIOUS MRNA VACCINES
[patent_app_type] => utility
[patent_app_number] => 16/639403
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639403 | EFFICACIOUS MRNA VACCINES | Aug 16, 2018 | Abandoned |
Array
(
[id] => 18517626
[patent_doc_number] => 11707496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Echovirus for treatment of tumors
[patent_app_type] => utility
[patent_app_number] => 16/641117
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 19506
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641117 | Echovirus for treatment of tumors | Aug 14, 2018 | Issued |
Array
(
[id] => 16009253
[patent_doc_number] => 20200179469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => SACCHAROMYCES BOULARDII FOR THE TREATMENT OF MOOD DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/638290
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638290
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638290 | None | Aug 9, 2018 | Issued |